PAR 2.56% 20.0¢ paradigm biopharmaceuticals limited..

Ann: Change of Director's Interest Notice, page-26

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,278 Posts.
    lightbulb Created with Sketch. 879
    Yes I tend to agree. Virus is still in play and will be for a minimum of atleast 2 months.
    With an increase in tests the graphs will steeply ascend, driving fear like a nail right through any economic stimulus headlines.

    PAR still very much a speccy (though de-risked significantly) and I expect this label to be a punishing one in the short term. The current SP is below my accumulation zone so I may start some small buys - but $0.845 is my main target from a volume/price perspective. This is an 80% discount from ATH. Unsure if we'll get there ofcourse but the probability of further SP drops is significant enough for me to wait.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.